IMD exclusion provisions in HR 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform; FFPSA Implementation
IMD exclusion reform
Annual appropriations for SAMHSA/SUPTRS Block Grant and Community Project Funding
LPFM broadcasting.
Duration: January 1, 2018
to
present
General Issues: Health Issues , Medicare/Medicaid , Budget/Appropriations , Communications/Broadcasting/Radio/TV , Telecommunications
Spending: about $250,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2018: U.S. Senate, House of Representatives, Federal Communications Commission (FCC)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Robert Zucker LD, Rep. Rothman; LA,Rep. Evans (IL); Sen. Lautenberg
LD, Rep. Rothman; LA, Rep. Evans (IL); Sen. Lautenberg
Charla Penn LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
Chelsey Hickman CoS, Rep. Kay Granger; LA Sen. Larry Craig
Molly McDonnell LC/LA/Senior Health Policy Advisor; Congressman Leonard Lance
Charla McManus LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on April 22.
Original Filing: 301574873.xml
Lobbying Issues
IMD exclusion provisions in HR 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform; FFPSA Implementation
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Lobbying Issues
Annual appropriations for SAMHSA/SUPTRS Block Grant and Community Project Funding
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Type of Issue
Communications/Broadcasting/Radio/TV
4th Quarter, 2023
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on Jan. 19.
Original Filing: 301532183.xml
Lobbying Issues
IMD exclusion provisions in HR 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform; FFPSA Implementation
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Lobbying Issues
Annual appropriations for SAMHSA/SUPTRS Block Grant and Community Project Funding
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on Oct. 18, 2023.
Original Filing: 301504268.xml
Lobbying Issues
IMD exclusion provisions in HR 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform; FFPSA Implementation
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Lobbying Issues
Annual appropriations for SAMHSA/SUPTRS Block Grant and Community Project Funding
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on July 18, 2023.
Original Filing: 301480164.xml
Lobbying Issues
IMD exclusion provisions in HR 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform; FFPSA Implementation
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Lobbying Issues
Annual appropriations for SAMHSA/SAPT Block Grant and Community Project Funding
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on April 19, 2023.
Original Filing: 301457289.xml
Lobbying Issues
IMD exclusion provisions in HR 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform; FFPSA Implementation
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Lobbying Issues
Annual appropriations for SAMHSA/SAPT Block Grant and Community Project Funding
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on Jan. 20, 2023.
Original Filing: 301438376.xml
Lobbying Issues
IMD exclusion provisions in HR 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform; FFPSA Implementation
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Lobbying Issues
Annual appropriations for SAMHSA/SAPT Block Grant and Community Project Funding
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on Oct. 19, 2022.
Original Filing: 301409173.xml
Lobbying Issues
IMD exclusion provisions in HR 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform; FFPSA Implementation
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Lobbying Issues
Annual appropriations for SAMHSA/SAPT Block Grant and Community Project Funding
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on July 19, 2022.
Original Filing: 301386427.xml
Lobbying Issues
IMD exclusion provisions in HR 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform; FFPSA Implementation
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to low power FM; frequency availability
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Annual appropriations for SAMHSA/SAPT Block Grant and Community Project Funding
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on April 20, 2022.
Original Filing: 301367204.xml
Lobbying Issues
IMD exclusion provisions in HR 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform; FFPSA Implementation
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to low power FM; frequency availability
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CARES Act implementation and emergency supplemental funding for SUD treatment related to the Coronavirus epidemic; CARES Act Implementation; Second round PPP relief for nonprofit organizations; CCSRA Implementation; American Rescue Plan Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on Jan. 20, 2022.
Original Filing: 301336466.xml
Lobbying Issues
IMD exclusion provisions in HR 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform; FFPSA Implementation
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to low power FM; frequency availability
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CARES Act implementation and emergency supplemental funding for SUD treatment related to the Coronavirus epidemic; CARES Act Implementation; Second round PPP relief for nonprofit organizations; CCSRA Implementation; American Rescue Plan Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on Oct. 19, 2021.
Original Filing: 301303601.xml
Lobbying Issues
IMD exclusion provisions in HR 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform; FFPSA Implementation
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to low power FM; frequency availability
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CARES Act implementation and emergency supplemental funding for SUD treatment related to the Coronavirus epidemic; CARES Act Implementation; Second round PPP relief for nonprofit organizations; CCSRA Implementation; American Rescue Plan Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on July 19, 2021.
Original Filing: 301283118.xml
Lobbying Issues
IMD exclusion provisions in HR 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform; FFPSA Implementation
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to low power FM; frequency availability
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CARES Act implementation and emergency supplemental funding for SUD treatment related to the Coronavirus epidemic; CARES Act Implementation; Second round PPP relief for nonprofit organizations; CCSRA Implementation; American Rescue Plan Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on April 19, 2021.
Original Filing: 301258210.xml
Lobbying Issues
IMD exclusion provisions in HR 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform; FFPSA Implementation
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to low power FM; frequency availability
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CARES Act implementation and emergency supplemental funding for SUD treatment related to the Coronavirus epidemic; CARES Act Implementation; Second round PPP relief for nonprofit organizations; CCSRA Implementation
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on Jan. 19, 2021.
Original Filing: 301234463.xml
Lobbying Issues
IMD exclusion provisions in H.R. 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform; Family First Prevention Services Act implementation
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to low power FM; frequency availability
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
ARES Act implementation and emergency supplemental funding for SUD treatment related to the Coronavirus epidemic; CARES Act Implementation for second round PPP relief for nonprofit organizations
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on Oct. 15, 2020.
Original Filing: 301210228.xml
Lobbying Issues
IMD exclusion provisions in H.R. 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform; Family First Prevention Services Act implementation
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to low power FM; frequency availability
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CARES Act implementation and emergency supplemental funding for SUD treatment related to the Coronavirus epidemic; HEALS Act funding for SUD treatment
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on July 15, 2020.
Original Filing: 301188178.xml
Lobbying Issues
IMD exclusion provisions in H.R. 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform; Family First Prevention Services Act implementation
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to low power FM; frequency availability
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CARES Act implementation and emergency supplemental funding for SUD treatment related to the Coronavirus epidemic
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on April 17, 2020.
Original Filing: 301169326.xml
Lobbying Issues
IMD exclusion provisions in H.R. 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform; Family First Prevention Services Act implementation
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to low power FM; frequency availability
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CARES Act implementation and emergency supplemental funding for SUD treatment related to the Coronavirus epidemic
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on Jan. 17, 2020.
Original Filing: 301108572.xml
Lobbying Issues
IMD exclusion provisions in H.R. 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform; Family First Prevention Services Act implementation
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to low power FM; frequency availability
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2019
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on Oct. 15, 2019.
Original Filing: 301065539.xml
Lobbying Issues
IMD exclusion provisions in H.R. 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on July 19, 2019.
Original Filing: 301050666.xml
Lobbying Issues
IMD exclusion provisions in H.R. 6 and SUPPORT Act; 42 CFR part 2 patient confidentiality reform
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on April 16, 2019.
Original Filing: 301026266.xml
Lobbying Issues
IMD exclusion provisions in H.R. 6 and SUPPORT Act
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on Jan. 17, 2019.
Original Filing: 301006244.xml
Lobbying Issues
IMD exclusion, monitored Road to Recovery Act; provisions related to IMD exclusion in HR 6, Opioid Crisis Response Act and enacted provisions in the SUPPORT for Patients and Communities Act, designated Public Law 115-271
Agencies Lobbied
U.S. Senate
Lobbying Issues
IMD exclusion; H.R. 5797 legislation related to reforming the IMD exclusion
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on Oct. 19, 2018.
Original Filing: 300991980.xml
Lobbying Issues
IMD exclusion, monitored Road to Recovery Act; provisions related to IMD exclusion in HR 6, Opioid Crisis Response Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
IMD exclusion; H.R. 5797 legislation related to reforming the IMD exclusion
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on July 19, 2018.
Original Filing: 300971765.xml
Lobbying Issues
IMD exclusion, monitored Road to Recovery Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
IMD exclusion; H.R. 5797 legislation related to reforming the IMD exclusion
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Odyssey House Louisiana, Inc. , earning $10,000. The report was filed on April 18, 2018.
Original Filing: 300947271.xml
Lobbying Issues
IMD exclusion, monitored Road to Recovery Act and HR 1892 provisions related to the Family First Prevention Services Act and SUD treatment
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...